This finding confirms and extends a previous observation that BCL-xL is the major BCL2 family member underlying the apoptotic resistance of the olaparib-induced senescence-like phenotype in ovarian and triple-negative breast cancer (TNBC) cells [74]. The gene discussed is BCL2; the disease is triple-negative breast carcinoma.